Search research articles
Contact Us
Filters
Showing results (111-120 of 256) with videos related to
Page
of 26
Sort By:
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|
October 11, 2005
Prebiotic carbohydrates in human milk and formulas
Günther Boehm, Bernd Stahl, Jürgen Jelinek, et al.
The Journal of Nutrition
|
May 22, 2008
Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life
Sertac Arslanoglu, Guido E Moro, Joachim Schmitt, et al.
European Journal of Clinical Pharmacology
|
June 12, 1979
Indobufen (K 3920), a new inhibitor of platelet aggregation: effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man
V Tamassia, G Corvi, L M Fuccella, et al.
Pharmacological Research
|
June 13, 2001
Gastric motor effects of triptans: open questions and future perspectives
G Cipolla, S Sacco, F Crema, et al.
International Journal of Clinical Pharmacology Research
|
January 1, 1984
Cross-over study of pharmacokinetics and haematological toxicity of 4'-epi-doxorubicin and doxorubicin in cancer patients
A Martini, E Moro, M A Pacciarini, et al.
Journal of the American College of Cardiology
|
April 1, 1986
Doppler and two-dimensional echocardiographic observations of systolic anterior motion of the mitral valve in d-transposition of the great arteries: an explanation of the left ventricular outflow tract gradient
E Moro, F J ten Cate, C Tirtaman, et al.
European Journal of Clinical Pharmacology
|
June 12, 1979
Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man
L M Fuccella, G Corvi, E Moro, et al.
Acta Diabetologica
|
December 5, 1998
Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation
E Moro, C Zambon, S Pianetti, et al.
Journal of Biological Regulators and Homeostatic Agents
|
November 20, 2012
Update of adjustable fortification regimen for preterm infants: a new protocol
S Arslanoglu, E Bertino, A Coscia, et al.
Gene Therapy
|
February 12, 1998
ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo
S Ferrari, E Moro, A Pettenazzo, et al.
Page
of 26
Search research articles
Search
Showing results (111-120 of 256) with videos related to
Sort By:
Page
of 26
Acta Paediatrica (Oslo, Norway : 1992). Supplement
|
October 11, 2005
Prebiotic carbohydrates in human milk and formulas
Günther Boehm, Bernd Stahl, Jürgen Jelinek, et al.
The Journal of Nutrition
|
May 22, 2008
Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life
Sertac Arslanoglu, Guido E Moro, Joachim Schmitt, et al.
European Journal of Clinical Pharmacology
|
June 12, 1979
Indobufen (K 3920), a new inhibitor of platelet aggregation: effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man
V Tamassia, G Corvi, L M Fuccella, et al.
Pharmacological Research
|
June 13, 2001
Gastric motor effects of triptans: open questions and future perspectives
G Cipolla, S Sacco, F Crema, et al.
International Journal of Clinical Pharmacology Research
|
January 1, 1984
Cross-over study of pharmacokinetics and haematological toxicity of 4'-epi-doxorubicin and doxorubicin in cancer patients
A Martini, E Moro, M A Pacciarini, et al.
Journal of the American College of Cardiology
|
April 1, 1986
Doppler and two-dimensional echocardiographic observations of systolic anterior motion of the mitral valve in d-transposition of the great arteries: an explanation of the left ventricular outflow tract gradient
E Moro, F J ten Cate, C Tirtaman, et al.
European Journal of Clinical Pharmacology
|
June 12, 1979
Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man
L M Fuccella, G Corvi, E Moro, et al.
Acta Diabetologica
|
December 5, 1998
Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation
E Moro, C Zambon, S Pianetti, et al.
Journal of Biological Regulators and Homeostatic Agents
|
November 20, 2012
Update of adjustable fortification regimen for preterm infants: a new protocol
S Arslanoglu, E Bertino, A Coscia, et al.
Gene Therapy
|
February 12, 1998
ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo
S Ferrari, E Moro, A Pettenazzo, et al.
Page
of 26